Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Adding new monoclonal antibody to chemotherapy improves survival in soft-tissue sarcoma patients

Adding a novel monoclonal antibody therapy to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma, a lethal soft-tissue cancer.

21 Jul 2016

Penn researchers develop plant-based oral vaccine booster

Jonas Salk created a vaccine against polio that has been used since 1955; Albert Sabin created another version that has been on the market since 1961. Together, these two vaccines have nearly eliminated polio from the face of the earth.

20 Jul 2016

Researchers develop antibody with potential therapeutic effects against multiple sclerosis

Inserm Unit U919, directed by Prof. Denis Vivien has developed an antibody with potential therapeutic effects against multiple sclerosis.

20 Jul 2016

Protein present on stem cell surface can boost growth of damaged muscle tissue

Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration caused by old age and diseases such as muscular dystrophy.

19 Jul 2016

Cancer immunotherapy could treat HIV

A type of immunotherapy that has shown promising results against cancer could also be used against HIV, the virus that causes AIDS.

17 Jul 2016

New treatment may destroy HIV's last refuge

UK scientists may have found a way to destroy HIV's last refuge. A study by Oxford University has confirmed that a treatment developed by a British company can remove the virus in its chosen hiding place, in laboratory conditions, offering hope of a viable treatment.

15 Jul 2016

Researchers identify novel therapeutic monoclonal antibodies from Zika-infected patients

A team of researchers from the Institute for Research in Biomedicine and the Swiss biotech company Humabs BioMed SA has identified novel therapeutic monoclonal antibody candidates isolated from Zika-infected patients and new strategies for Zika virus diagnostics.

14 Jul 2016

Moderate caloric restriction in healthy non-obese individuals reduces chronic inflammation

Eating less may help us lead longer, healthier lives, according to the new results from a large, multicenter study, led by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.

14 Jul 2016

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Cancer remains a leading cause of death worldwide, and the global cancer burden is expected to increase by 70 percent over the next two decades.

14 Jul 2016

Study finds evidence that PD-1 antibody may benefit men with metastatic prostate cancer

Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients. Now a new study out of the OHSU Knight Cancer Institute is reviving hope that the approach also may help men with life-threatening prostate cancer.

14 Jul 2016

UCLA scientists identify mechanisms of tumor resistance to immunotherapy in advanced melanoma

UCLA researchers have for the first time identified mechanisms that determine how advanced melanoma can become resistant to immune checkpoint inhibitors, a discovery that could lead to the development of new and improved treatments for the deadliest type of skin cancer.

13 Jul 2016

Antibodies from survivors of filovirus infection may offer protection against other filoviral diseases

Ebola and Marburg filovirus disease outbreaks have typically occurred as isolated events, confined to central Africa.

13 Jul 2016

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

The American Autoimmune Related Diseases Association, Inc. is spotlighting two new research studies originally reported in ScienceDaily.

13 Jul 2016

Researchers identify mechanisms triggering hypergammaglobulinemia

Some autoimmune diseases and persistent infections are characterized by high levels of antibodies in the blood. But what are the causes of this hypergammaglobulinemia? A team headed by INRS's Professor Simona Stäger has successfully identified the mechanisms triggering the phenomenon.

12 Jul 2016

Antibody News and Research

Further Reading

Adding new monoclonal antibody to chemotherapy improves survival in soft-tissue sarcoma patients

Penn researchers develop plant-based oral vaccine booster

Researchers develop antibody with potential therapeutic effects against multiple sclerosis

Protein present on stem cell surface can boost growth of damaged muscle tissue

Cancer immunotherapy could treat HIV

New treatment may destroy HIV's last refuge

Researchers identify novel therapeutic monoclonal antibodies from Zika-infected patients

Moderate caloric restriction in healthy non-obese individuals reduces chronic inflammation

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Study finds evidence that PD-1 antibody may benefit men with metastatic prostate cancer

UCLA scientists identify mechanisms of tumor resistance to immunotherapy in advanced melanoma

Antibodies from survivors of filovirus infection may offer protection against other filoviral diseases

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

Researchers identify mechanisms triggering hypergammaglobulinemia

Chromatrap reports benefits of ChIP technology in ground breaking research

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

Study results pave way to development of effective human vaccine against HIV

Innovative nanobubble treatment finds and destroys cancer cells in mice

Experts discuss potential of DNA origami

WRAIR collaborates with Sanofi Pasteur to develop ZPIV vaccine candidate

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News